Au Kenya, le cancer du col de l’utérus est le deuxième cancer le plus fréquent et la première cause de décès par cancer chez les femmes, avec environ 10 décès quotidiens (GLOBOCAN 2022). Suite à un projet pilote dans le comté de Kitui (2013–2015), le vaccin HPV a été introduit à l’échelle nationale en octobre […]
Topic: Service Delivery
Défis et bonnes pratiques pour maintenir la prestation après l’introduction du MAC: l’expérience du Nigéria dans l’élimination du cancer du col de l’utérus
Au Nigéria, la vaccination contre le HPV a été introduite en deux phases — Phase 1 ciblant 16 États (2023) et Phase 2 couvrant 21 États supplémentaires (octobre 2024) — avec une routinisation immédiate après chaque campagne de cohortes multi-âges (MAC). La combinaison des campagnes et de la vaccination de routine a permis d’atteindre environ […]
Exploration des stratégies de prestation de services, de leur fréquence et des tendances à long terme de la couverture via les plateformes scolaires – Ouganda
En Ouganda, la vaccination HPV a débuté par un projet pilote en 2007, avant un déploiement national en 2015 ciblant les filles de 10 ans via un modèle hybride scolaire et basé sur l’âge. La présentation retrace les jalons du programme, incluant les évaluations post-introduction, les perturbations liées au COVID-19 et la reprise post-pandémique. La […]
Exploration des stratégies de prestation de services, de leur fréquence et des tendances à long terme de la couverture via les plateformes scolaires. – Rouanda
Au Rwanda, premier pays en Afrique à introduire la vaccination HPV (2011), le programme a évolué en trois phases : un modèle de campagne scolaire par niveau (2011–2014), une intégration dans la vaccination de routine ciblant les filles de 12 ans (dès 2015), et un schéma à dose unique depuis 2024. Plus de 2 millions […]
Efficacy Of Quadrivalent Human Papillomavirus Vaccine Among Kenyan Adolescents And Young Adults Living With HIV Nine Years After Initial Vaccination
In Kenya, a nine-year follow-up of a cohort of 180 adolescents living with HIV who received three doses of the quadrivalent HPV vaccine at ages 9–14 found sustained vaccine-specific protection, with zero persistent infections detected for HPV types 11, 16, or 18 among 151 evaluable participants. Only two participants (1.3%) had any vaccine-genotype persistent infection, […]
Using Geographic information System mapping for Evidence-Based Planning to Reach HPV vaccine Target Girls and Zero-Dose Children: Experience from Jigjiga Town, Ethiopia.
In Ethiopia, a 20-day house-to-house GIS mapping exercise conducted in Jigjiga town (Somali region) between August and September 2024 revealed major discrepancies between projected and actual target populations: official estimates placed the HPV-eligible girl population at 6,770, while the headcount identified 11,300 — a 67% undercount — and 14,935 girls were ultimately vaccinated, representing 132% […]
Expanding HPV vaccine Programs to Older Adolescent Girls or Young Boys: Immunization Stakeholder Perspectives in 11 Low- and Middle-Income Countries
Semi-structured interviews with 22 national immunization program managers and advisors across 11 LMICs conducted between May and August 2025 examined stakeholder perspectives on expanding HPV vaccination to older adolescent girls (15–18 years) and young boys (9–14 years). Slightly more stakeholders prioritized older girls, citing continued vaccine effectiveness post-sexual debut, independent health-seeking capacity, and evidence from […]
Overcoming Barriers To Human Papillomavirus Vaccine Uptake In Sierra Leone: Insights From Formative Research In Four Low-Performing Districts
In Sierra Leone, HPV vaccination coverage fell sharply from over 100% in 2022 to 31.3% in 2023, prompting CHAI and the Ministry of Health EPI programme to conduct formative research across the four lowest-performing districts — Bonthe, Koinadugu, Kenema, and Western Area Rural. A mixed-methods study combining facility data audits and semi-structured interviews with healthcare […]
Using Routine Human Papillomavirus Vaccination Data to Guide High-Impact Community Outreach in Nigeria
In Nigeria, routine HPV vaccination coverage among nine-year-old girls remains low in Kano State, constrained by limited awareness, persistent myths, and geographic and economic barriers. Pathfinder International used DHIS2 data to identify low-coverage local government areas and implemented targeted community outreach in collaboration with State Primary Health Care Development Boards, deploying trained vaccination teams alongside […]
Formative insights to optimize the systematic medical visits, an integrated package of health services including HPV vaccination, in Côte d’Ivoire.
In Côte d’Ivoire, the national systematic medical visits (VMS) programme has integrated HPV vaccination since September 2023, combining it with multicomponent adolescent health services including screenings, nutrition assessments, and reproductive health counselling. Despite coverage gains, implementation remains uneven across delivery settings, with logistical gaps, limited intersectoral coordination, and inequitable cost distribution identified as key barriers […]